These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3433866)

  • 1. 10-year results and survival of patients with hypertrophic cardiomyopathy treated with calcium antagonists.
    Hopf R; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():137-44. PubMed ID: 3433866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hypertrophic cardiomyopathy: relation to pathological mechanisms.
    Kaltenbach M; Hopf R
    J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():59-68. PubMed ID: 4040978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persisting effect of Ca(2+)-channel blockers on left ventricular function in hypertrophic cardiomyopathy after 14 years' treatment.
    Hartmann A; Schnell J; Hopf R; Kneissl G
    Angiology; 1996 Aug; 47(8):765-73. PubMed ID: 8712479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy.
    Rosing DR; Idänpään-Heikkilä U; Maron BJ; Bonow RO; Epstein SE
    Am J Cardiol; 1985 Jan; 55(3):185B-195B. PubMed ID: 3881913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conservative medical treatment of hypertrophic myocardiopathies].
    Kaltenbach M; Hopf R
    Z Kardiol; 1982 Dec; 71(12):795-805. PubMed ID: 6891871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)].
    Kaltenbach M; Hopf R; Keller M
    Dtsch Med Wochenschr; 1976 Aug; 101(35):1284-7. PubMed ID: 8298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy.
    Hopf R; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():105-12. PubMed ID: 3433863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-obstructive hypertrophic cardiomyopathy and systolic compression of 3 coronary arteries. Long-term improvement with verapamil].
    Juliard JM; Charlier P; Nitenberg A; Mérillon JP; Masquet C; Gourgon R
    Ann Med Interne (Paris); 1987; 138(7):512-6. PubMed ID: 3439674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serial changes in left ventricular configuration and function in hypertrophic cardiomyopathy].
    Horita Y; Genda A; Shimizu Y; Sugihara N; Suematsu T; Kita Y; Takeda R
    J Cardiol; 1988 Sep; 18(3):651-64. PubMed ID: 3249282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy.
    Wagner JA; Sax FL; Weisman HF; Porterfield J; McIntosh C; Weisfeldt ML; Snyder SH; Epstein SE
    N Engl J Med; 1989 Mar; 320(12):755-61. PubMed ID: 2537929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of calcium channel blockers in hypertrophic cardiomyopathy.
    Lorell BH
    Am J Med; 1985 Feb; 78(2B):43-54. PubMed ID: 4038850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of diltiazem on regional left ventricular diastolic filling dynamics in patients with hypertrophic cardiomyopathy as assessed by color kinesis.
    Ito T; Suwa M; Imai M; Hozumi T; Tonari S; Kitaura Y
    Circ J; 2004 Nov; 68(11):1035-40. PubMed ID: 15502385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypertrophic obstructive cardiomyopathy with verapamil.
    Kaltenbach M; Hopf R; Kober G; Bussmann WD; Keller M; Petersen Y
    Br Heart J; 1979 Jul; 42(1):35-42. PubMed ID: 573129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertensive hypertrophic cardiomyopathy of the elderly.
    Topol EJ; Traill TA; Fortuin NJ
    N Engl J Med; 1985 Jan; 312(5):277-83. PubMed ID: 2857050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium antagonist agents in hypertrophic cardiomyopathy.
    Chatterjee K
    Am J Cardiol; 1987 Jan; 59(3):146B-152B. PubMed ID: 3812266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T; Hess OM; Jenni R; Krayenbühl HP
    Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hypertrophic cardiomyopathy with nifedipine and propranolol in combination].
    Hopf R; Thomas J; Klepzig H; Kaltenbach M
    Z Kardiol; 1987 Aug; 76(8):469-78. PubMed ID: 3673167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium antagonists in cardiomyopathy].
    Takabatake Y
    Nihon Rinsho; 1991 Jan; 49(1):168-75. PubMed ID: 2002597
    [No Abstract]   [Full Text] [Related]  

  • 20. [Complex hemodynamic analysis of left ventricular systole in hypertrophic cardiopathy--clinical implications].
    Dabrowski M; Górecka B; Witkowski A; Ruzyłło W
    Kardiol Pol; 1990; 33(5):288-302. PubMed ID: 2074625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.